NSTGQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NSTGQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
NanoString Technologies has the Growth Rank of 6.
GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:
1. 5-year revenue growth rate, the higher, the better.GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.
Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.
For the Medical Instruments & Supplies subindustry, NanoString Technologies's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, NanoString Technologies's Growth Rank distribution charts can be found below:
* The bar in red indicates where NanoString Technologies's Growth Rank falls into.
Thank you for viewing the detailed overview of NanoString Technologies's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Jonathan Todd Garland | officer: Chief Commercial Officer | C/O CYTEK BIOSCIENCES, INC., 47215 LAKEVIEW BOULEVARD, FREMONT CA 94538 |
K Thomas Bailey | officer: Chief Financial Officer | 1618 STATION STREET, VANCOUVER A1 V6A 1B6 |
R Bradley Gray | director, officer: President and CEO | 530 FAIRVIEW AVENUE NORTH, SUITE 2000, SEATTLE WA 98109 |
William Young | director | 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142 |
Waite Charles P Jr | director, 10 percent owner | 11023 NE 116TH STREET, KIRKLAND WA 98034 |
Gregory Norden | director | 16640 CHESTERFIELD GROVE DRIVE, SUITE 200, CHESTERFIELD MO 63005 |
Elisha W Finney | director | C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304 |
Teresa M. Foy | director | 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109 |
Joseph M Beechem | officer: SVP, Research & Development | 530 FAIRVIEW AVENUE NORTH, SUITE 2000, SEATTLE WA 98109 |
John D. Gerace | officer: Chief Commercial Officer | C/O NANOSTRING TECHNOLOGIES, INC., 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109 |
Kirk Malloy | director | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
J. Chad Brown | officer: SVP, Sales & Marketing | 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109 |
Robert Hershberg | director | 3005 FIRST AVENUE, SEATTLE WA 98121 |
Janet George | director | 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109 |
Dana E. Rollison | director | 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109 |
From GuruFocus
By GuruFocus Research • 02-08-2024
By GuruFocus Research • 02-08-2024
By GuruFocus Research • 02-08-2024
By GuruFocus Research • 02-08-2024
By Business Wire • 02-12-2024
By GuruFocus Research • 02-08-2024
By GuruFocus Research • 02-08-2024
By GuruFocus Research • 02-08-2024
By GuruFocus Research • 02-08-2024
By GuruFocus Research • 02-08-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.